Завершено
Фаза IV
Россия
Remicade; Orencia; Ro-Actemra; Mabthera · Medical University of Vienna
A Randomized, Multi-Center Biomarker Trial to Predict Therapeutic Responses of Patients With Rheumatoid Arthritis to a Specific Biologic Mode of Action